GLUE
Price
$5.66
Change
-$0.10 (-1.74%)
Updated
Jan 17 closing price
Capitalization
347.42M
53 days until earnings call
RNTX
Price
$2.00
Change
+$0.03 (+1.52%)
Updated
Jan 17 closing price
Capitalization
43.33M
Ad is loading...

GLUE vs RNTX

Header iconGLUE vs RNTX Comparison
Open Charts GLUE vs RNTXBanner chart's image
Monte Rosa Therapeutics
Price$5.66
Change-$0.10 (-1.74%)
Volume$631.11K
Capitalization347.42M
Rein Therapeutics
Price$2.00
Change+$0.03 (+1.52%)
Volume$18.37K
Capitalization43.33M
GLUE vs RNTX Comparison Chart
Loading...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLUE vs. RNTX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLUE is a Hold and RNTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (GLUE: $5.66 vs. RNTX: $2.00)
Brand notoriety: GLUE and RNTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLUE: 46% vs. RNTX: 18%
Market capitalization -- GLUE: $347.42M vs. RNTX: $43.33M
GLUE [@Biotechnology] is valued at $347.42M. RNTX’s [@Biotechnology] market capitalization is $43.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLUE’s FA Score shows that 0 FA rating(s) are green whileRNTX’s FA Score has 1 green FA rating(s).

  • GLUE’s FA Score: 0 green, 5 red.
  • RNTX’s FA Score: 1 green, 4 red.
According to our system of comparison, both GLUE and RNTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLUE’s TA Score shows that 4 TA indicator(s) are bullish.

  • GLUE’s TA Score: 4 bullish, 4 bearish.

Price Growth

GLUE (@Biotechnology) experienced а -0.79% price change this week, while RNTX (@Biotechnology) price change was -5.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

GLUE is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLUE($347M) has a higher market cap than RNTX($43.3M). RNTX YTD gains are higher at: -13.043 vs. GLUE (-18.516).
GLUERNTXGLUE / RNTX
Capitalization347M43.3M801%
EBITDA-121.07MN/A-
Gain YTD-18.516-13.043142%
P/E RatioN/AN/A-
Revenue15MN/A-
Total Cash242MN/A-
Total Debt43.7MN/A-
FUNDAMENTALS RATINGS
RNTX: Fundamental Ratings
RNTX
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLUE
RSI
ODDS (%)
Bullish Trend 11 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 11 days ago
85%
Momentum
ODDS (%)
Bearish Trend 11 days ago
90%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
87%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
87%
Aroon
ODDS (%)
Bearish Trend 11 days ago
89%
View a ticker or compare two or three
Ad is loading...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ASVDX10.950.08
+0.74%
American Century Small Cap Value R6
CSIFX44.940.27
+0.60%
Calvert Balanced A
CICGX9.790.04
+0.41%
AB Concentrated International Growth C
UBPIX11.95N/A
N/A
ProFunds UltraLatin America Inv
GMHPX12.55N/A
N/A
Goldman Sachs Rising Dividend Gr P

RNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNTX has been closely correlated with ALRN. These tickers have moved in lockstep 100% of the time. This A.I.-generated data suggests there is a high statistical probability that if RNTX jumps, then ALRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNTX
1D Price
Change %
RNTX100%
+1.52%
ALRN - RNTX
100%
Closely correlated
N/A
CABA - RNTX
21%
Poorly correlated
+12.76%
IBIO - RNTX
20%
Poorly correlated
-0.35%
GLUE - RNTX
20%
Poorly correlated
-1.82%
ANEB - RNTX
20%
Poorly correlated
-1.55%
More